Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ALAS2 |
| Upstream (Parents) |
|---|
| (<<) HBD → ALAS2 |
| (<<) HBG2///HBG1 → ALAS2 |
| (<<) HBA2///HBA1 → ALAS2 |
| (<<) FCGR3B → ALAS2 |
| (<<) SEL1L → ALAS2 |
| (<<) RAMP3 → ALAS2 |
| (<<) SNCA → ALAS2 |
| Downstream (Children) |
|---|
| ALAS2 → ADARB2 (>>) |
| ALAS2 → HBD (>>) |
| ALAS2 → HBQ1 (>>) |
| ALAS2 → MTMR10 (>>) |
| ALAS2 → HBG2///HBG1 (>>) |
| ALAS2 → HBA2///HBA1 (>>) |
| ALAS2 → PTGER1 (>>) |
| ALAS2 → EFCAB1 (>>) |
| ALAS2 → EPAG (>>) |
| ALAS2 → SLC4A1 (>>) |
| ALAS2 → MYO3A (>>) |
| ALAS2 → REEP2 (>>) |
| ALAS2 → GYPB (>>) |
| ALAS2 → UBR4 (>>) |
| ALAS2 → SEL1L (>>) |
| ALAS2 → SNCA (>>) |
| ALAS2 → SURF1 (>>) |
